Instead of 2nd dose of rbaivax 1ml can't we give abhayrab 0.5ml.vaccine
Reading File
Finding Sources
Searching the Web
Abhayrab 0.5ml vs Rabipur 1ml interchangeable rabies PEP vaccine dose substitution
Finding Sources
Searching the Web
Abhayrab PVRV 0.5ml Rabipur PCEC 1ml interchangeable mid-course WHO guidelines India
Here is a thorough answer based on Indian guidelines, WHO guidance, and the Abhayrab product characteristics:
Can Abhayrab 0.5 mL Replace Rabivax 1 mL for the 2nd Dose?
Understanding the two vaccines
| Feature | Rabivax (HDCV) | Abhayrab (PVRV) |
|---|---|---|
| Vaccine type | Human Diploid Cell Vaccine | Purified Vero Cell Rabies Vaccine |
| IM dose volume | 1 mL | 0.5 mL |
| Potency (min) | ≥2.5 IU/dose | ≥2.5 IU/dose |
| Manufacturer | Serum Institute of India | Human Biologicals Institute |
| ID dose | 0.1 mL | 0.1 mL |
Both vaccines meet the WHO minimum potency standard of ≥2.5 IU per dose, even though the IM volumes differ. The difference in volume (0.5 mL vs 1 mL) reflects formulation, not a difference in protective antigenic units.
Short answer: Yes, it is acceptable - with conditions
WHO and India's National Guidelines on Rabies Prophylaxis explicitly allow switching between modern cell-culture vaccines mid-course when necessary. The WHO SEARO guide for rabies PEP states:
"When completion of PEP with the same modern rabies vaccine is not possible, the switch can be done provided vaccine [potency and schedule are maintained]."
The same guidance also notes:
"The dose is either 1 single immunizing IM dose (1 mL or 0.5 mL, depending on vaccine type)"
This directly addresses your question - 0.5 mL is the correct full IM dose for Abhayrab/Verorab-type PVRV vaccines, just as 1 mL is the full dose for Rabivax/Rabipur-type PCEC/HDCV vaccines. You are not giving a "half dose" - you are giving the complete, labeled dose for that product.
Key conditions for switching
- Give the full dose for the substitute vaccine - Abhayrab IM = 0.5 mL (this is the full dose, not a reduced one).
- Continue the same schedule - Do not restart Day 0. Continue with Day 3, 7, 14, 28 as planned.
- Ideally use the same vaccine throughout - Indian guidelines (as per the KIMS Community Medicine FAQ book on Rabies Prevention) state: "As far as possible, the same vaccine should be used throughout a course." Switching is acceptable when unavoidable.
- Both vaccines must be DCGI/WHO-approved cell-culture vaccines - Rabivax and Abhayrab both qualify.
- ID route special note - If switching to the ID route, 0.1 mL per site is standard for all vaccines regardless of their IM volume.
Why the volumes differ but are equivalent
- Abhayrab/Verorab (PVRV) contains ≥2.5 IU in 0.5 mL of reconstituted vaccine.
- Rabivax/Rabipur (HDCV/PCEC) contains ≥2.5 IU in 1 mL of reconstituted vaccine.
- The antigen content per dose is equivalent - the volume difference is due to formulation concentration only.
Clinical trials on Abhayrab confirmed equivalent immunogenicity whether reconstituted to 0.5 mL or 1 mL, and whether given IM or ID.
Bottom line
Giving Abhayrab 0.5 mL IM in place of Rabivax 1 mL IM for the 2nd dose is clinically acceptable provided:
- Rabivax is unavailable or the switch is necessary
- The rest of the schedule continues uninterrupted
- 0.5 mL is the full labeled IM dose for Abhayrab - it is not a dose reduction
This is supported by WHO interchangeability guidance and Indian National Rabies Prophylaxis Guidelines. Both vaccines are approved cell-culture vaccines meeting the same minimum potency standard.
Calcified granuloma at 87 of liver as incidental finding on ct
Reading File
Asking for Preferences
Asking for Preferences
Calcified granuloma at segment 7 of liver
Finding Sources
Searching the Web
calcified granuloma liver incidental finding CT management significance
Finding Sources
Searching the Web
calcified liver granuloma CT segment 7 causes workup no further investigation needed
Here is a complete clinical breakdown:
Calcified Granuloma in Liver Segment 7 - Incidental CT Finding
What is it?
A calcified granuloma is the end-stage, healed remnant of a prior granulomatous reaction. The granuloma has undergone dystrophic calcification, meaning it is biologically inactive - a "tombstone" of an old inflammatory event. Segment 7 is in the posterior right lobe, a common location since the right lobe receives the majority of portal blood flow (and blood-borne pathogens).
Common Causes (in order of likelihood in India)
| Cause | Notes |
|---|---|
| Tuberculosis | Most common cause worldwide; liver affected in disseminated/miliary TB |
| Histoplasmosis | Common in endemic areas; multiple small calcified granulomas |
| Sarcoidosis | Non-caseating granulomas; liver involved in ~2/3 of sarcoid cases |
| Schistosomiasis | Parasitic; portal fibrosis pattern |
| Fascioliasis / Hydatid | Parasitic; usually larger, peripheral calcification |
| Old brucellosis | Livestock exposure |
| Drug reaction (healed) | Rare; history of offending drug |
| Idiopathic | No cause identified; common |
CT Characteristics of a Benign Calcified Granuloma
- Small, typically <1-2 cm
- Dense, homogeneous calcification involving the entire lesion
- Well-defined margins, no surrounding edema or enhancement
- No internal or peripheral enhancement on contrast phases
- May be solitary or multiple
- Often co-existing calcified granulomas in lungs and spleen suggest systemic granulomatous disease
Clinical Significance
Calcified granulomas are almost universally benign and clinically silent. Key points:
- They represent healed, inactive disease - no active infection
- They carry no malignant potential
- They do not require biopsy, resection, or treatment by themselves
- Segment location (7 vs. others) does not change management
What Further Work-Up is Needed?
The extent of investigation depends on clinical context:
No further work-up needed if:
- Lesion has classic dense homogeneous calcification with no soft tissue component
- No constitutional symptoms (fever, weight loss, night sweats)
- Normal liver function tests
- No immunocompromised state
- No known malignancy (where metastasis needs exclusion)
Consider limited work-up if:
- Systemic symptoms present - check CXR (for TB/sarcoid), ESR, Mantoux/IGRA
- Multiple granulomas in liver + spleen + lung on the same CT - suggests past disseminated granulomatous disease (TB most likely in India); check IGRA/TST, CXR
- Immunocompromised patient (HIV, on steroids, transplant) - active granulomatous disease cannot be excluded; LFTs + IGRA warranted
- Atypical CT features (soft tissue component, enhancement, large size >2 cm, irregular margins) - consider MRI or biopsy to exclude other diagnoses (e.g., cholangiocarcinoma with calcification, fibrolamellar HCC)
- Raised ALP/GGT out of proportion - consider sarcoidosis workup (serum ACE, CXR)
What to Tell the Patient / Document
"Incidental calcified granuloma in liver segment 7 on CT. This represents a healed, benign inflammatory reaction - most likely from a past granulomatous infection (e.g., TB or histoplasmosis). It is not cancer and does not require treatment. No follow-up imaging is needed unless symptoms develop."
Bottom Line
A solitary, densely calcified, non-enhancing granuloma in segment 7 found incidentally on CT is a benign, inactive finding requiring no further imaging or treatment in an asymptomatic patient with normal liver function. A brief clinical history for prior TB exposure or systemic symptoms is all that is typically warranted. The ACR Incidental Findings guidelines support reassurance and no routine follow-up for classic calcified granulomas on CT.
This is a shared conversation. Sign in to Orris to start your own chat.